Uncategorized
Enrollment begins for phase 1/2 clinical study of topical presbyopia drug
Patient enrollment has begun for a phase 1/2 clinical trial of EV06, a topical treatment for presbyopia being developed by Encore Vision.The compound is designed to reverse age-related changes in the crystalline lens that decrease lens elasticity and accommodative amplitude.